Perbedaan Merck Tbk. dan Midi Utama Indonesia Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Midi Utama Indonesia Tbk. diperdagangkan di Rp282 (kapitalisasi pasar 9,5 T, volume 24 jam 1,62 jt). Perbedaan utamanya: Midi Utama Indonesia Tbk. jauh lebih besar — sekitar 5,6× kapitalisasi pasar Merck Tbk., dan Midi Utama Indonesia Tbk. lebih aktif diperdagangkan (1,62 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | MIDI | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 9,5 T |
Volume | 37,6 rb | 1,62 jt |
Lot | 376 | 16,19 rb |
Perputaran | 144,47 jt | 454,66 jt |
Harga Rata-rata | 3.842,23 | 280,76 |
Nilai Transaksi | 144,47 jt | 454,66 jt |
Harga Ekuilibrium Indikatif | 3.840 | 282 |
Volume Ekuilibrium Indikatif | 7 | 803 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Midi Utama Indonesia (the company) was established under its original name of PT Midimart Utama base on notarial deed No.37 of Mr Frans Elsius, S.H, dated on 28 Jun, 2007. The Company’s articles of association has been amended several times, most recently by notarial deed No. 2 of Kamelina, S.H., dated Mar 3, 2010, concerning among others, increase in capital paid up and public offering.
Selengkapnya di halaman MIDI →